Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

P3 Health Partners (PIII) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for P3 Health Partners (PIII) over the last 6 years, with Q3 2025 value amounting to $369.8 million.

  • P3 Health Partners' Cost of Revenue fell 799.44% to $369.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year decrease of 88.48%. This contributed to the annual value of $1.6 billion for FY2024, which is 2629.15% up from last year.
  • According to the latest figures from Q3 2025, P3 Health Partners' Cost of Revenue is $369.8 million, which was down 799.44% from $351.3 million recorded in Q2 2025.
  • Over the past 5 years, P3 Health Partners' Cost of Revenue peaked at $410.2 million during Q4 2024, and registered a low of $134.1 million during Q4 2021.
  • For the 5-year period, P3 Health Partners' Cost of Revenue averaged around $291.4 million, with its median value being $285.6 million (2023).
  • As far as peak fluctuations go, P3 Health Partners' Cost of Revenue soared by 8129.37% in 2022, and later crashed by 799.44% in 2025.
  • Over the past 5 years, P3 Health Partners' Cost of Revenue (Quarter) stood at $134.1 million in 2021, then skyrocketed by 100.68% to $269.2 million in 2022, then surged by 36.59% to $367.7 million in 2023, then rose by 11.57% to $410.2 million in 2024, then decreased by 9.86% to $369.8 million in 2025.
  • Its Cost of Revenue was $369.8 million in Q3 2025, compared to $351.3 million in Q2 2025 and $372.0 million in Q1 2025.